Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2436-2025

WATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems. Recall

WATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems.

FDA recall Class I

Ongoing

FDA lists this Class I recall for WATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2436-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jul 29, 2025
FDA report date
Sep 10, 2025
Quantity in commerce
340185 units in total
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

WATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems.

Affected model & UDI checker

Search the exact identifiers published for Z-2436-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedWATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems.Check source notice00191506022310
FDA code information

GTIN 00191506022310, ALL NON-EXPIRED BATCHES

View the original FDA recall notice

Why was this product recalled?

Boston Scientific has identified a higher likelihood of air embolism events when procedures are performed without positive pressure-controlled ventilation. According to published literature and clinical data, in percutaneous procedures requiring transseptal access to the left atrium when conscious or deep sedation is used, patients have an approximately three-times higher risk (U.S. study) of negative left atrium pressure and air ingress. This risk is especially prevalent in patients with pre-existing low left atrial pressure, hypovolemia, and partial upper airway collapse.

What actions did BOSTON SCIENTIFIC CORPORATION take?

Boston Scientific issued an Important Medical Device Advisory notice to its consignees on 07/29/2025 via FedEx. The notice explained the problem with the device, procedures under which the likelihood of the problem occurs, and risk to the patient. The WATCHMAN Access Systems Instructions for Use (IFUs) and WATCHMAN physician training will be updated to emphasize instructions related to Access System air management. This update will strengthen the information provided to clinicians regarding the potential for air embolism during WATCHMAN procedures performed under conscious or deep sedation and provide potential mitigation strategies. No devices are being removed. Instructions: 1. Review IFU updates related to air embolism as detailed in Appendix 2. These updates will be added to the WATCHMAN Access Systems IFUs and WATCHMAN Physician Training. 2. Forward this letter to any other clinicians in your medical facility who perform WATCHMAN procedures and to any facilities where affected devices have been transferred, including hospitals or sites within your network. If you are a distributor, this notice must be forwarded to your customers to ensure notification of this Medical Device Advisory is carried out to the end-user level. 3. Complete and return the enclosed Acknowledgment Form. If additional assistance is required or more information regarding this communication, customer should contact your local Boston Scientific representative or Sr. Quality Systems Manager at 763-494-1133.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology
Z-2436-2025: WATCHMAN TruSteer Access System, US, Material Number (UPN) M635TU90050;intended to provide vasc recall | MedtechLedger